
    
      1. Objectives 1.1 Primary objective • To determine the efficacy of vorinostat plus FND as
           an induction treatment

             -  Response rate of vorinostat/FND 1.2 Secondary objective

                  -  Survival outcome

             -  Overall survival and progression-free survival

                  -  To determine the efficacy of vorinostat maintenance treatment

             -  Relapse rate • Toxicity of vorinostat/FND

             -  Hematologic and non-hematologic toxicity
    
  